ZA200108627B - Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments. - Google Patents

Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments. Download PDF

Info

Publication number
ZA200108627B
ZA200108627B ZA200108627A ZA200108627A ZA200108627B ZA 200108627 B ZA200108627 B ZA 200108627B ZA 200108627 A ZA200108627 A ZA 200108627A ZA 200108627 A ZA200108627 A ZA 200108627A ZA 200108627 B ZA200108627 B ZA 200108627B
Authority
ZA
South Africa
Prior art keywords
formula
compounds
radical
compound
carbon atoms
Prior art date
Application number
ZA200108627A
Other languages
English (en)
Inventor
Jacques Demassey
Michel Klich
Branislav Musicki
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of ZA200108627B publication Critical patent/ZA200108627B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/075—Benzo[b]pyran-2-ones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA200108627A 1999-04-19 2001-10-19 Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments. ZA200108627B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904866A FR2792320B1 (fr) 1999-04-19 1999-04-19 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
ZA200108627B true ZA200108627B (en) 2002-10-21

Family

ID=9544554

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108627A ZA200108627B (en) 1999-04-19 2001-10-19 Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments.

Country Status (24)

Country Link
US (1) US6579902B1 (cg-RX-API-DMAC7.html)
EP (1) EP1173455A2 (cg-RX-API-DMAC7.html)
JP (1) JP2002542253A (cg-RX-API-DMAC7.html)
KR (1) KR100693258B1 (cg-RX-API-DMAC7.html)
CN (1) CN1213055C (cg-RX-API-DMAC7.html)
AP (1) AP2001002312A0 (cg-RX-API-DMAC7.html)
AU (1) AU769514B2 (cg-RX-API-DMAC7.html)
CA (1) CA2363945A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20013708A3 (cg-RX-API-DMAC7.html)
EA (1) EA004304B1 (cg-RX-API-DMAC7.html)
FR (1) FR2792320B1 (cg-RX-API-DMAC7.html)
HK (1) HK1046690B (cg-RX-API-DMAC7.html)
HU (1) HUP0200778A3 (cg-RX-API-DMAC7.html)
ID (1) ID30562A (cg-RX-API-DMAC7.html)
IL (1) IL146018A0 (cg-RX-API-DMAC7.html)
NO (1) NO320703B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ515108A (cg-RX-API-DMAC7.html)
PL (1) PL354192A1 (cg-RX-API-DMAC7.html)
SK (1) SK14842001A3 (cg-RX-API-DMAC7.html)
TR (1) TR200103009T2 (cg-RX-API-DMAC7.html)
UA (1) UA72919C2 (cg-RX-API-DMAC7.html)
WO (1) WO2000063222A2 (cg-RX-API-DMAC7.html)
YU (1) YU80301A (cg-RX-API-DMAC7.html)
ZA (1) ZA200108627B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844273B1 (fr) * 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
KR100649357B1 (ko) * 2004-05-04 2006-11-24 제일약품주식회사 항염증 활성을 갖는 크로멘-2-온 모핵 히드록사민 산유도체, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물
US7622451B2 (en) * 2004-11-03 2009-11-24 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
AU2005301957B2 (en) * 2004-11-03 2012-02-23 Department Of Health And Human Services Novobiocin analogues as anticancer agents
US9120774B2 (en) 2004-11-03 2015-09-01 University Of Kansas Novobiocin analogues having modified sugar moieties
US8212011B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues
US8212012B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues having modified sugar moieties
US7960353B2 (en) * 2007-05-10 2011-06-14 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
WO2010014617A1 (en) * 2008-07-28 2010-02-04 University Of Kansas Heat shock protein 90 inhibitor dosing methods
US20110082098A1 (en) * 2009-09-30 2011-04-07 University Of Kansas Novobiocin analogues and treatment of polycystic kidney disease
MX2025007723A (es) 2018-05-14 2025-08-01 Reata Pharmaceuticals Inc Biarilamidas con grupos de azucar modificados para el tratamiento de enfermedades asociadas con la trayectoria de la proteina de choque de calor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652536A (en) * 1969-06-02 1972-03-28 Upjohn Co Novenamine compounds and derivatives
US3890297A (en) * 1973-03-29 1975-06-17 Upjohn Co Process for n-acylating novenamine

Also Published As

Publication number Publication date
EA200101100A1 (ru) 2002-04-25
SK14842001A3 (sk) 2003-05-02
HK1046690B (zh) 2006-03-10
WO2000063222A2 (fr) 2000-10-26
NO320703B1 (no) 2006-01-16
YU80301A (sh) 2005-07-19
UA72919C2 (uk) 2005-05-16
JP2002542253A (ja) 2002-12-10
FR2792320A1 (fr) 2000-10-20
CZ20013708A3 (cs) 2002-04-17
WO2000063222A3 (fr) 2001-05-31
NO20015058L (no) 2001-12-17
AU769514B2 (en) 2004-01-29
HUP0200778A3 (en) 2003-03-28
CN1213055C (zh) 2005-08-03
KR100693258B1 (ko) 2007-03-13
PL354192A1 (en) 2003-12-29
FR2792320B1 (fr) 2003-05-09
IL146018A0 (en) 2002-07-25
CA2363945A1 (fr) 2000-10-26
ID30562A (id) 2001-12-20
CN1357001A (zh) 2002-07-03
TR200103009T2 (tr) 2002-05-21
US6579902B1 (en) 2003-06-17
EA004304B1 (ru) 2004-02-26
KR20020008155A (ko) 2002-01-29
NZ515108A (en) 2004-01-30
HK1046690A1 (en) 2003-01-24
AU4125600A (en) 2000-11-02
AP2001002312A0 (en) 2001-12-31
EP1173455A2 (fr) 2002-01-23
HUP0200778A2 (hu) 2002-07-29
NO20015058D0 (no) 2001-10-18

Similar Documents

Publication Publication Date Title
EP0799833B1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments
CA2102454C (fr) Derives de l'erythromycine, leur procede de preparation, leur application comme medicaments
EP0885234B1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0222353B1 (en) Macrolide antibiotic derivatives
KR20110119699A (ko) 데옥시악타가르딘 유도체
US5583115A (en) Dialkyltiacumicin compounds
EP0195359B1 (en) Basic monocarboxyamide derivatives of actagardine having antibiotic activity
CN101959849A (zh) 作为抗菌剂的新型半合成糖肽
JPS61251696A (ja) 新規化合物,その製法及びそれを含む医薬組成物
EP0222186B1 (en) Erythromycin derivatives /a
CN113975396A (zh) 包含β-内酰胺类化合物的药物组合物及其用途
MXPA97008611A (en) Compounds of dialquiltiacumic
DE68925806T2 (de) C63-Amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplaninen
WO2024053836A1 (ko) 항생제 내성균에 대한 항균 활성을 가지는 항균 펩타이드 h103b 및 이의 용도
EP0974598B1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments
WO2001081373A2 (en) Glycopeptide antibacterial compounds and methods of using same
EP1284984B1 (fr) Derives de l'uridine comme antibiotiques
CA2258152C (fr) Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
WO2016159537A1 (ko) 파이토스핑고신 유도체 및 이를 함유하는 조성물
HK1047940A1 (en) 9A-azalides with antibacterial activity
FR2702480A1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US6720308B1 (en) Anhydrolide derivatives having antibacterial activity
WO2017048029A1 (ko) 클라바스피린 펩타이드 유사체를 유효성분으로 함유하는 항염증용 조성물
JPH0216320B2 (cg-RX-API-DMAC7.html)
CA2247175C (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments